IVI receives $15.7 million to conduct Ph III trials of typhoid vaccine https://www.outsourcing-pharma.com/Article/2019/04/23/IVI-receives-15.7m-to-conduct-Ph-III-trials-of-typhoid-vaccine? Outsourcing-pharma.com, 2019/04/23 Related postsUniversity of the Witwatersrand | International Vaccine Institute Board of Trustees appoints Witsie as ChairRead more
